![Richard Crowley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Actualmente, Richard Crowley es Director de Operaciones y Vicepresidente Ejecutivo de Novavax, Inc. En el pasado, el Sr. Crowley ocupó el cargo de Vicepresidente Ejecutivo de Operaciones y Garantía de Calidad en TerSera Therapeutics LLC, Copresidente y Director de Operaciones en Savient Pharmaceuticals, Inc. y Vicepresidente Senior de Operaciones Biofarmacéuticas en ImClone LLC y Director de Fabricación de Productos Biológicos en BASF Bioresearch Corp. Se licenció en la Universidad de Denison y se graduó en la Universidad de Pensilvania.
Antiguos cargos conocidos de Richard Crowley.
Empresas | Cargo | Fin |
---|---|---|
NOVAVAX, INC. | Director de Operaciones | 20/11/2023 |
Crealta Pharmaceuticals LLC
![]() Crealta Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Crealta Pharmaceuticals LLC operates as a specialty pharmaceutical company. The firm pursuing the acquisition of specialty pharmaceutical products with a focus on select therapeutic areas. The company was founded in August 2013 and is headquartered in Lake Forest, IL. | Corporate Officer/Principal | 01/01/2016 |
TerSera Therapeutics LLC
![]() TerSera Therapeutics LLC Pharmaceuticals: MajorHealth Technology TerSera Therapeutics LLC develops pharmaceutical products. Its therapeutic areas include allergy or immunology, CNS disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies, urology, and women's health. The company was founded by Edward J. Fiorentino in 2016 and is headquartered in Lake Forest, IL. | Director de Operaciones | - |
SAVIENT PHARMACEUTICALS INC | Presidente | - |
BASF Bioresearch Corp. | Corporate Officer/Principal | - |
Formación de Richard Crowley.
Denison University | Undergraduate Degree |
University of Pennsylvania | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NOVAVAX, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
ImClone LLC
![]() ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
BASF Bioresearch Corp. | |
Savient Pharmaceuticals, Inc.
![]() Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
TerSera Therapeutics LLC
![]() TerSera Therapeutics LLC Pharmaceuticals: MajorHealth Technology TerSera Therapeutics LLC develops pharmaceutical products. Its therapeutic areas include allergy or immunology, CNS disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies, urology, and women's health. The company was founded by Edward J. Fiorentino in 2016 and is headquartered in Lake Forest, IL. | Health Technology |
Crealta Pharmaceuticals LLC
![]() Crealta Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Crealta Pharmaceuticals LLC operates as a specialty pharmaceutical company. The firm pursuing the acquisition of specialty pharmaceutical products with a focus on select therapeutic areas. The company was founded in August 2013 and is headquartered in Lake Forest, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Richard Crowley